Symbol |
Name |
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
ACAN
|
aggrecan
|
ACPP
|
acid phosphatase, prostate
|
ADA
|
adenosine deaminase
|
ADAM17
|
ADAM metallopeptidase domain 17
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
ADRB2
|
adrenoceptor beta 2, surface
|
AFP
|
alpha-fetoprotein
|
AGER
|
advanced glycosylation end product-specific receptor
|
AHR
|
aryl hydrocarbon receptor
|
AIRE
|
autoimmune regulator
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
ALOX15
|
arachidonate 15-lipoxygenase
|
ANGPT2
|
angiopoietin 2
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
ANXA1
|
annexin A1
|
AP2A2
|
adaptor-related protein complex 2, alpha 2 subunit
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
APOA1
|
apolipoprotein A-I
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
APOE
|
apolipoprotein E
|
APP
|
amyloid beta (A4) precursor protein
|
ARF6
|
ADP-ribosylation factor 6
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
AURKA
|
aurora kinase A
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
BANF1
|
barrier to autointegration factor 1
|
BCL2
|
B-cell CLL/lymphoma 2
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
BIRC5
|
baculoviral IAP repeat containing 5
|
BIRC7
|
baculoviral IAP repeat containing 7
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
BRAP
|
BRCA1 associated protein
|
BRD4
|
bromodomain containing 4
|
BST2
|
bone marrow stromal cell antigen 2
|
BTLA
|
B and T lymphocyte associated
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
C6ORF120
|
chromosome 6 open reading frame 120
|
C6ORF25
|
chromosome 6 open reading frame 25
|
CAMP
|
cathelicidin antimicrobial peptide
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
CCL11
|
chemokine (C-C motif) ligand 11
|
CCL17
|
chemokine (C-C motif) ligand 17
|
CCL19
|
chemokine (C-C motif) ligand 19
|
CCL20
|
chemokine (C-C motif) ligand 20
|
CCL21
|
chemokine (C-C motif) ligand 21
|
CCL22
|
chemokine (C-C motif) ligand 22
|
CCL24
|
chemokine (C-C motif) ligand 24
|
CCL3
|
chemokine (C-C motif) ligand 3
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
CCL4
|
chemokine (C-C motif) ligand 4
|
CCL5
|
chemokine (C-C motif) ligand 5
|
CCNT1
|
cyclin T1
|
CCR2
|
chemokine (C-C motif) receptor 2
|
CCR3
|
chemokine (C-C motif) receptor 3
|
CCR4
|
chemokine (C-C motif) receptor 4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
CCR6
|
chemokine (C-C motif) receptor 6
|
CCR7
|
chemokine (C-C motif) receptor 7
|
CCR8
|
chemokine (C-C motif) receptor 8
|
CCR9
|
chemokine (C-C motif) receptor 9
|
CD14
|
CD14 molecule
|
CD160
|
CD160 molecule
|
CD19
|
CD19 molecule
|
CD1D
|
CD1d molecule
|
CD2
|
CD2 molecule
|
CD209
|
CD209 molecule
|
CD226
|
CD226 molecule
|
CD24
|
CD24 molecule
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
CD247
|
CD247 molecule
|
CD27
|
CD27 molecule
|
CD274
|
CD274 molecule
|
CD28
|
CD28 molecule
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
CD38
|
CD38 molecule
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
CD4
|
CD4 molecule
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
CD40LG
|
CD40 ligand
|
CD44
|
CD44 molecule (Indian blood group)
|
CD46
|
CD46 molecule, complement regulatory protein
|
CD47
|
CD47 molecule
|
CD5
|
CD5 molecule
|
CD53
|
CD53 molecule
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
CD59
|
CD59 molecule, complement regulatory protein
|
CD6
|
CD6 molecule
|
CD63
|
CD63 molecule
|
CD69
|
CD69 molecule
|
CD7
|
CD7 molecule
|
CD70
|
CD70 molecule
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
CD80
|
CD80 molecule
|
CD81
|
CD81 molecule
|
CD86
|
CD86 molecule
|
CD8A
|
CD8a molecule
|
CD8B
|
CD8b molecule
|
CD9
|
CD9 molecule
|
CD99
|
CD99 molecule
|
CDK9
|
cyclin-dependent kinase 9
|
CDKL2
|
cyclin-dependent kinase-like 2 (CDC2-related kinase)
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
CEL
|
carboxyl ester lipase
|
CFL1
|
cofilin 1 (non-muscle)
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
CISH
|
cytokine inducible SH2-containing protein
|
CLDN2
|
claudin 2
|
CLEC4A
|
C-type lectin domain family 4, member A
|
CLEC4C
|
C-type lectin domain family 4, member C
|
CLECL1
|
C-type lectin-like 1
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
COPS5
|
COP9 signalosome subunit 5
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
CREM
|
cAMP responsive element modulator
|
CRP
|
C-reactive protein, pentraxin-related
|
CSAG2
|
CSAG family, member 2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
CTAG1B
|
cancer/testis antigen 1B
|
CTAG2
|
cancer/testis antigen 2
|
CTGF
|
connective tissue growth factor
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
CTSL
|
cathepsin L
|
CTSV
|
cathepsin V
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
DEFB4A
|
defensin, beta 4A
|
DLL1
|
delta-like 1 (Drosophila)
|
DNASE1
|
deoxyribonuclease I
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
DPP4
|
dipeptidyl-peptidase 4
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
DUSP6
|
dual specificity phosphatase 6
|
EBI3
|
Epstein-Barr virus induced 3
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
EOMES
|
eomesodermin
|
EPO
|
erythropoietin
|
EPOR
|
erythropoietin receptor
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
F2
|
coagulation factor II (thrombin)
|
F2R
|
coagulation factor II (thrombin) receptor
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
F8
|
coagulation factor VIII, procoagulant component
|
FAP
|
fibroblast activation protein, alpha
|
FAS
|
Fas cell surface death receptor
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
FGF2
|
fibroblast growth factor 2 (basic)
|
FLG
|
filaggrin
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
FOSL2
|
FOS-like antigen 2
|
FOXO1
|
forkhead box O1
|
FOXO3
|
forkhead box O3
|
FOXP3
|
forkhead box P3
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
GATA3
|
GATA binding protein 3
|
GDE1
|
glycerophosphodiester phosphodiesterase 1
|
GNLY
|
granulysin
|
GPR15
|
G protein-coupled receptor 15
|
GSK3B
|
glycogen synthase kinase 3 beta
|
GSN
|
gelsolin
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
HAMP
|
hepcidin antimicrobial peptide
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
HLA-A
|
major histocompatibility complex, class I, A
|
HLA-B
|
major histocompatibility complex, class I, B
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
HLA-G
|
major histocompatibility complex, class I, G
|
HMGB1
|
high mobility group box 1
|
HMOX1
|
heme oxygenase 1
|
HNF1A
|
HNF1 homeobox A
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
HRH4
|
histamine receptor H4
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
HTATSF1
|
HIV-1 Tat specific factor 1
|
ICAM1
|
intercellular adhesion molecule 1
|
ICAM3
|
intercellular adhesion molecule 3
|
ICOS
|
inducible T-cell co-stimulator
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
IFI16
|
interferon, gamma-inducible protein 16
|
IFI30
|
interferon, gamma-inducible protein 30
|
IFNA1
|
interferon, alpha 1
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
IFNB1
|
interferon, beta 1, fibroblast
|
IFNG
|
interferon, gamma
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
IFNL3
|
interferon, lambda 3
|
IGHE
|
immunoglobulin heavy constant epsilon
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
IL10
|
interleukin 10
|
IL10RA
|
interleukin 10 receptor, alpha
|
IL12A
|
interleukin 12A
|
IL12B
|
interleukin 12B
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
IL13
|
interleukin 13
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
IL15
|
interleukin 15
|
IL15RA
|
interleukin 15 receptor, alpha
|
IL16
|
interleukin 16
|
IL17A
|
interleukin 17A
|
IL17D
|
interleukin 17D
|
IL17F
|
interleukin 17F
|
IL17RB
|
interleukin 17 receptor B
|
IL18
|
interleukin 18
|
IL18R1
|
interleukin 18 receptor 1
|
IL1A
|
interleukin 1, alpha
|
IL1B
|
interleukin 1, beta
|
IL2
|
interleukin 2
|
IL21
|
interleukin 21
|
IL22
|
interleukin 22
|
IL23A
|
interleukin 23, alpha subunit p19
|
IL23R
|
interleukin 23 receptor
|
IL25
|
interleukin 25
|
IL27
|
interleukin 27
|
IL2RA
|
interleukin 2 receptor, alpha
|
IL2RB
|
interleukin 2 receptor, beta
|
IL2RG
|
interleukin 2 receptor, gamma
|
IL3
|
interleukin 3
|
IL31
|
interleukin 31
|
IL33
|
interleukin 33
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
IL4
|
interleukin 4
|
IL4I1
|
interleukin 4 induced 1
|
IL5
|
interleukin 5
|
IL6
|
interleukin 6
|
IL6R
|
interleukin 6 receptor
|
IL7
|
interleukin 7
|
IL7R
|
interleukin 7 receptor
|
IL9
|
interleukin 9
|
IRF1
|
interferon regulatory factor 1
|
IRF4
|
interferon regulatory factor 4
|
ITGA1
|
integrin, alpha 1
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
ITGB7
|
integrin, beta 7
|
ITK
|
IL2-inducible T-cell kinase
|
JAK1
|
Janus kinase 1
|
JAK2
|
Janus kinase 2
|
JUN
|
jun proto-oncogene
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
KDR
|
kinase insert domain receptor
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
KLF2
|
Kruppel-like factor 2
|
KLK4
|
kallikrein-related peptidase 4
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
KRT7
|
keratin 7, type II
|
LAG3
|
lymphocyte-activation gene 3
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
LAT
|
linker for activation of T cells
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
LEF1
|
lymphoid enhancer-binding factor 1
|
LEP
|
leptin
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
LIF
|
leukemia inhibitory factor
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
LRRC32
|
leucine rich repeat containing 32
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
LTB4R2
|
leukotriene B4 receptor 2
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
LTF
|
lactotransferrin
|
LY75
|
lymphocyte antigen 75
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
MAGEA3
|
melanoma antigen family A3
|
MAGEA6
|
melanoma antigen family A6
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
MAPK14
|
mitogen-activated protein kinase 14
|
MAPK8
|
mitogen-activated protein kinase 8
|
MAPT
|
microtubule-associated protein tau
|
MBD2
|
methyl-CpG binding domain protein 2
|
MBD4
|
methyl-CpG binding domain protein 4
|
MBP
|
myelin basic protein
|
MCAM
|
melanoma cell adhesion molecule
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
MECP2
|
methyl CpG binding protein 2
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
MICA
|
MHC class I polypeptide-related sequence A
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
MIR132
|
microRNA 132
|
MIR142
|
microRNA 142
|
MIR155
|
microRNA 155
|
MIR15A
|
microRNA 15a
|
MIR17
|
microRNA 17
|
MIR181A1
|
microRNA 181a-1
|
MIR181A2
|
microRNA 181a-2
|
MIR181B1
|
microRNA 181b-1
|
MIR181C
|
microRNA 181c
|
MIR184
|
microRNA 184
|
MIR200A
|
microRNA 200a
|
MIR21
|
microRNA 21
|
MIR210
|
microRNA 210
|
MIR223
|
microRNA 223
|
MIR24-1
|
microRNA 24-1
|
MIR29A
|
microRNA 29a
|
MIR451A
|
microRNA 451a
|
MLANA
|
melan-A
|
MMP2
|
matrix metallopeptidase 2
|
MMP9
|
matrix metallopeptidase 9
|
MOG
|
myelin oligodendrocyte glycoprotein
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
MPZL2
|
myelin protein zero-like 2
|
MSH2
|
mutS homolog 2
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
MUC1
|
mucin 1, cell surface associated
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
NCAM1
|
neural cell adhesion molecule 1
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
NCS1
|
neuronal calcium sensor 1
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
NFIB
|
nuclear factor I/B
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
NOS2
|
nitric oxide synthase 2, inducible
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
NPPA
|
natriuretic peptide A
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
OSM
|
oncostatin M
|
OSMR
|
oncostatin M receptor
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
PANX1
|
pannexin 1
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
PDCD1
|
programmed cell death 1
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
PHPT1
|
phosphohistidine phosphatase 1
|
PI4K2B
|
phosphatidylinositol 4-kinase type 2 beta
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
PLSCR1
|
phospholipid scramblase 1
|
PLSCR4
|
phospholipid scramblase 4
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
PON1
|
paraoxonase 1
|
POU5F1
|
POU class 5 homeobox 1
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
PRF1
|
perforin 1 (pore forming protein)
|
PRTN3
|
proteinase 3
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
PTGDR2
|
prostaglandin D2 receptor 2
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
PTH
|
parathyroid hormone
|
PTK2
|
protein tyrosine kinase 2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
RAB4A
|
RAB4A, member RAS oncogene family
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
RAG1
|
recombination activating gene 1
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
RUNX1
|
runt-related transcription factor 1
|
S100A7
|
S100 calcium binding protein A7
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
SAMHD1
|
SAM domain and HD domain 1
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
SDC2
|
syndecan 2
|
SDC4
|
syndecan 4
|
SELL
|
selectin L
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
SELPLG
|
selectin P ligand
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
SH2D1A
|
SH2 domain containing 1A
|
SHH
|
sonic hedgehog
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
SLAMF6
|
SLAM family member 6
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
SMAD3
|
SMAD family member 3
|
SMAD7
|
SMAD family member 7
|
SOCS1
|
suppressor of cytokine signaling 1
|
SOCS3
|
suppressor of cytokine signaling 3
|
SPN
|
sialophorin
|
SPP1
|
secreted phosphoprotein 1
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
STAT4
|
signal transducer and activator of transcription 4
|
STAT5A
|
signal transducer and activator of transcription 5A
|
STAT5B
|
signal transducer and activator of transcription 5B
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
SUPT7L
|
suppressor of Ty 7 (S. cerevisiae)-like
|
SUSD2
|
sushi domain containing 2
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
SYCP1
|
synaptonemal complex protein 1
|
SYN1
|
synapsin I
|
TBX21
|
T-box 21
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
TERT
|
telomerase reverse transcriptase
|
TGFB1
|
transforming growth factor, beta 1
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
THY1
|
Thy-1 cell surface antigen
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
TLN1
|
talin 1
|
TLR2
|
toll-like receptor 2
|
TLR3
|
toll-like receptor 3
|
TLR4
|
toll-like receptor 4
|
TLR7
|
toll-like receptor 7
|
TLR8
|
toll-like receptor 8
|
TLR9
|
toll-like receptor 9
|
TMC8
|
transmembrane channel-like 8
|
TNF
|
tumor necrosis factor
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
TP53
|
tumor protein p53
|
TP63
|
tumor protein p63
|
TPI1
|
triosephosphate isomerase 1
|
TRB
|
T cell receptor beta locus
|
TRIM27
|
tripartite motif containing 27
|
TRIM5
|
tripartite motif containing 5
|
TRIP6
|
thyroid hormone receptor interactor 6
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
TSLP
|
thymic stromal lymphopoietin
|
UBXN11
|
UBX domain protein 11
|
ULBP2
|
UL16 binding protein 2
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
VEGFA
|
vascular endothelial growth factor A
|
VIM
|
vimentin
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
WFDC1
|
WAP four-disulfide core domain 1
|
WT1
|
Wilms tumor 1
|
XCL1
|
chemokine (C motif) ligand 1
|
XPO1
|
exportin 1
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|